↓ Skip to main content

From an understanding of etiopathogenesis to novel therapies—what is new in the treatment of celiac disease?

Overview of attention for article published in Frontiers in Pharmacology, April 2024
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
From an understanding of etiopathogenesis to novel therapies—what is new in the treatment of celiac disease?
Published in
Frontiers in Pharmacology, April 2024
DOI 10.3389/fphar.2024.1378172
Pubmed ID
Authors

Kinga Skoracka, Szymon Hryhorowicz, Francesco Tovoli, Alberto Raiteri, Anna Maria Rychter, Ryszard Słomski, Agnieszka Dobrowolska, Alessandro Granito, Iwona Krela-Kaźmierczak

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 20%
Student > Postgraduate 2 20%
Student > Bachelor 1 10%
Unknown 5 50%
Readers by discipline Count As %
Unspecified 2 20%
Pharmacology, Toxicology and Pharmaceutical Science 1 10%
Nursing and Health Professions 1 10%
Medicine and Dentistry 1 10%
Unknown 5 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2024.
All research outputs
#23,198,967
of 25,853,983 outputs
Outputs from Frontiers in Pharmacology
#12,544
of 20,029 outputs
Outputs of similar age
#169,390
of 212,953 outputs
Outputs of similar age from Frontiers in Pharmacology
#85
of 271 outputs
Altmetric has tracked 25,853,983 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,029 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,953 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 271 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.